Caxton Associates (New York)’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,909
| Closed | -$180K | – | 645 |
|
|
2023
Q1 | $180K | Sell |
1,909
-171
| -8% | -$16.2K | 0.03% | 425 |
|
|
2022
Q4 | $203K | Hold |
2,080
| – | – | 0.01% | 363 |
|
|
2022
Q3 | $537K | Buy |
2,080
+1,409
| +210% | +$364K | 0.07% | 209 |
|
|
2022
Q2 | $125K | Sell |
671
-271
| -29% | -$50.5K | 0.01% | 486 |
|
|
2022
Q1 | $92K | Hold |
942
| – | – | 0.01% | 447 |
|
|
2021
Q4 | $154K | Buy |
+942
| New | +$154K | 0.02% | 483 |
|
|
2020
Q1 | – | Sell |
-183
| Closed | -$130K | – | 574 |
|
|
2019
Q4 | $130K | Buy |
+183
| New | +$130K | 0.02% | 368 |
|